Two-in-one: A pooled analysis of primary hepatic neuroendocrine carcinoma combined/collided with hepatocellular carcinoma

Hepatobiliary Pancreat Dis Int. 2020 Aug;19(4):399-403. doi: 10.1016/j.hbpd.2020.03.012. Epub 2020 Apr 8.

Authors

Jia-Xi Mao¹, Fei Teng¹, Ke-Yan Sun¹, Cong Liu¹, Guo-Shan Ding¹, Wen-Yuan Guo²

Affiliations

¹ Department of Liver Surgery and Organ Transplantation, Changzheng Hospital, Navy Medical University, Shanghai 200003, China.
² Department of Liver Surgery and Organ Transplantation, Changzheng Hospital, Navy Medical University, Shanghai 200003, China. Electronic address: guowenyuan@smmu.edu.cn.

PMID: 32359724
DOI: 10.1016/j.hbpd.2020.03.012

No abstract available

Keywords: Collision tumor; Combined tumor; High malignancy; Operation; Rare disease.

Publication types

Letter
Review

MeSH terms

Biomarkers, Tumor / blood
Carcinoma, Hepatocellular / blood
Carcinoma, Hepatocellular / pathology*
Carcinoma, Hepatocellular / surgery
Carcinoma, Neuroendocrine / blood
Carcinoma, Neuroendocrine / pathology*
Carcinoma, Neuroendocrine / surgery
Humans
Liver Neoplasms / blood
Liver Neoplasms / pathology*
Liver Neoplasms / surgery
Neoplasm Recurrence, Local* / pathology
Neoplasms, Complex and Mixed / blood
Neoplasms, Complex and Mixed / pathology*
Neoplasms, Complex and Mixed / surgery
Neoplasms, Multiple Primary / blood
Neoplasms, Multiple Primary / pathology*
Neoplasms, Multiple Primary / surgery
Prognosis
Survival Rate

Substances

Biomarkers, Tumor